ARTICLE | Clinical News
Isavuconazole: Phase III amended
July 22, 2013 7:00 AM UTC
Basilea said the time point to assess the primary endpoint of overall response was amended in the double-blind, international Phase III ACTIVE trial of IV and oral isavuconazole to the end of IV treat...